The Lancet Neurology in conversation with

Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

July 13, 2022 The Lancet Neurology
The Lancet Neurology in conversation with
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy
Show Notes

Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology.

Read the full article:
The Boston criteria version 2.0 for cerebral amyloid angiopathy

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv